OSR Health (OSRHW) Capital Expenditures (2023)

OSR Health (OSRHW) posted Capital Expenditures of $2.1 million for Q1 2023.

OSR Health (OSRHW) Capital Expenditures (2023) Analysis & Trends

OSR Health has reported Capital Expenditures for 1 years, with the latest figure at $2.1 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Vertex Pharmaceuticals	138.97 Bn	131.12 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	85.15 Bn	77.15 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	62.84 Bn	57.65 Bn	1.37 Bn	-
4	Moderna	55.74 Bn	50.60 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.53 Bn	36.43 Bn	1.53 Bn	25.02 Mn
6	Alnylam Pharmaceuticals	31.60 Bn	28.29 Bn	992.69 Mn	34.68 Mn
7	BioNTech SE	27.32 Bn	8.93 Bn	668.28 Mn	-73.57 Mn
8	Royalty Pharma	27.29 Bn	26.45 Bn	-	251.02 Mn
9	Insmed	26.99 Bn	25.83 Bn	358.27 Mn	6.26 Mn
10	OSR Health	1.40 Mn	20.39 Mn	86,605.00	-

Download Data

Date	Value
Mar 31, 2023	2.07 Mn
Mar 31, 2023	2.07 Mn